Zacks Research Has Bearish Estimate for IRWD Q2 Earnings
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Analysts at Zacks Research decreased their Q2 2025 EPS estimates for Ironwood Pharmaceuticals in a research note issued on Wednesday, May 28th. Zacks Research analyst R. Department now expects that the biotechnology company will post earnings per share of ($0.04) for the quarter, down from their prior […]
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Analysts at Zacks Research decreased their Q2 2025 EPS estimates for Ironwood Pharmaceuticals in a research note issued on Wednesday, May 28th. Zacks Research analyst R. Department now expects that the biotechnology company will post earnings per share of ($0.04) for the quarter, down from their prior […]
